Palo Alto's Syapse Raises $10 Million To Power Precision Medicine

PALO ALTO, Calif. and WAYNE, Pa., July 10, 2014—Syapse, creators of the Precision Medicine Data Platform, today announced that it raised $10 million in Series B financing, led by Safeguard Scientifics (NYSE:SFE) with participation from Series A investor, The Social+Capital Partnership. This financing will enable Syapse to extend its lead in helping healthcare providers deploy precision medicine programs to utilize genomics and clinical data to support treatment decisions. In addition, Syapse will use proceeds to expand sales, marketing and client services, as well as further accelerate product development. To date, Syapse has raised a total of $14.5 million.

Help employers find you! Check out all the jobs and post your resume.